Skip to content

Early diagnosis and individualized treatment of Parkinson's disease based on gut-brain-axis

Early diagnosis and individualized treatment of Parkinson's disease based on gut-brain-axis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081951
Enrollment
Unknown
Registered
2024-03-18
Start date
2022-12-17
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

PD with chronic appendicitis/PD without chronic appendicitis:NA

Sponsors

The First Affiliated Hospital of University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: According to the 2015 International Movement Disorder Society (MDS) diagnostic criteria (PD syndrome criteria) 1. Patients demonstrates bradykinesia with tremor, rigidity, or both. 2. All participants signed informed consent forms 3. Coagulation function is generally normal

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. Patients treatment with dopamine blockers or dopamine-depleting agents, and the doses and courses are consistent with drug-induced Parkinson's diseases; 2. Functional neuroimaging of Presynaptic dopamine is normal. 3. Suffered severe brain injury or underwent complex craniotomy within 5 years; 4. Patients diagnosed with Alzheimer's disease, frontotemporal dementia, and Niemann-Pick diseases; 5. People diagnosed with severe neuropsychiatric disorders (epilepsy, bipolar disorder, major depressive episode, etc.) according to the DSM-V; 6. Complicated with serious systemic diseases, consciousness disorders, stroke, serious coronary heart disease, diabetes, liver and kidney diseases, and serious visual and hearing disorder; 7. Patients with Severe organic or functional dysphagia; 8. Patients who were unable to complete follow-up visit and auxiliary examinations as required by the study protocol

Design outcomes

Primary

MeasureTime frame
Intestinal microorganism;imaging features of appendix ;Constipation scale;Fecal microorganisms and metabolites;

Secondary

MeasureTime frame
Unified Parkinson's Disease Rating Scale (UPDRS);Non-motor symptoms scales;Cognitive scales;Parkinson disease sleep scale; Blood pressure monitoring;Residual urine measurement;UPDRS-? score improvement of Levodopa challenge test;Related indicators of blood immune cell metabolites ;The quality of PET-CT imaging;brain MRI data;

Countries

China

Contacts

Public ContactChen Yuhua

The First Affiliated Hospital of University of Science and Technology of China

doctorcyh@163.com+86 159 5523 6270

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026